1. Home
  2. ACST

as 05-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Pharmaceuticals and Biotechnology

Nasdaq

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: PRINCETON
Market Cap: 25.4M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 23.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.73 EPS Growth: N/A
52 Week Low/High: $1.72 - $3.84 Next Earning Date: 06-21-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: